Saga Diagnostics
ExitedBiotechnology; Genetics; Medical
Saga Diagnostics has raised €14M across 2 funding rounds from 2 investors, most recently a round in Jul 2021. Based in Lund, Sweden; founded 2016; active in Healthtech. Acquired by Foundation Medicine in 2026. Data as of 4 Nov 2026.
Total raised
€14M
€14,157,237
Funding rounds
2
Investors
2
distinct backers
Active since
2019-04
latest 2021-07
Funding by year
EUR raised per yearSaga Diagnostics — funding by year — interactive chart.
Data table
| Saga Diagnostics — funding by year | |
|---|---|
| 2019 | €3.7M |
| 2021 | €10M |
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-01 | Other | €10M | Segulah Medical Acceleration | View deal → |
| 2019-04-01 | Series A | €3.7M | Hadean Ventures | View deal → |
Exit
Type
acquisition
Date
Apr 2026
Value
€504M
Acquiror
Foundation Medicine (United States of America)
Related news
Similar companies
same sector, similar size- NuvoAir€13MSweden · Healthtech
- Qbtech€15MSweden · Healthtech
- Visiba Care€12MSweden · Healthtech
- Doktor€14MSweden · Healthtech
- Capitainer€13MSweden · Healthtech
- OnDosis€9.1MSweden · Healthtech
Global coverage: FundingData